Precision fermentation specialist LIVZYM BIOTECHNOLOGIES has closed its Series A funding round, securing $11.0M to advance its work in microbial engineering and large-scale enzyme production. The company, which has been developing sustainable, high-impact solutions since 2014, focuses on creating environmentally friendly, scalable products tailored to diverse industrial needs.
LIVZYM's core business involves producing high-performance enzymes, leveraging cutting-edge biotechnology to power a wide range of industries with efficiency and sustainability. They also excel in scaling fermentation from lab to large-scale production, offering end-to-end services including strain development, scale-up, and CDMO/CMO solutions.
.png&w=3840&q=75)
